Saeda, Shota
Sumi, Yukiyoshi
Fujiwara, Koichi
Kadotani, Hiroshi
Article History
Received: 22 May 2024
Accepted: 26 August 2024
First Online: 4 September 2024
Declarations
:
: This study was approved by the Research Ethics Committee of Shiga University of Medical Science (R2017-199). This study was part of the investigation into risk factors for phenoconversion and also had been approved by the committee (R2017-160). Written informed consent to participate was obtained from all patients.
: Not applicable.
: Hiroshi Kadotani was supported by donations from Fukuda Life Tech Co., Ltd., Fukuda Life Tech Keiji Co., Ltd., and Kadotani Kids Clinic to the Shiga University of Medical Science. Hiroshi Kadotani received Merck Sharp and Dohme Corp/MSD K.K. (the Investigator-initiated Studies Program), Eisai Co., Ltd., and the SECOM Science and Technology Foundation. The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck Sharp and Dohme Corp/MSD K.K. The other authors declare no conflicts of interest.